| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.742 | 24.357 | 33.979 | 44.487 | 51.375 |
| Total Income - EUR | - | - | - | - | - | 9.742 | 24.357 | 33.979 | 44.487 | 51.701 |
| Total Expenses - EUR | - | - | - | - | - | 992 | 2.546 | 3.458 | 10.908 | 18.483 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 8.750 | 21.811 | 30.520 | 33.579 | 33.218 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.473 | 21.095 | 29.706 | 33.143 | 31.899 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Allreumatest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 8.084 | 6.630 | 5.135 | 3.640 |
| Current Assets | - | - | - | - | - | 8.655 | 13.288 | 23.544 | 28.931 | 64.970 |
| Inventories | - | - | - | - | - | 0 | 0 | 1.558 | 40 | 40 |
| Receivables | - | - | - | - | - | 173 | 883 | 869 | 5.194 | -13 |
| Cash | - | - | - | - | - | 8.483 | 12.405 | 21.117 | 23.696 | 64.943 |
| Shareholders Funds | - | - | - | - | - | 8.514 | 21.136 | 29.747 | 33.184 | 64.898 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 141 | 236 | 428 | 882 | 3.712 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Allreumatest S.r.l.